OAM
BVS icon

Oxford Asset Management’s Bioventus BVS Stock Holding History

Oxford Asset Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,838
Closed -$145K – 551
2025
Q1 		$145K Buy
+15,838
New +$158K 0.07% 397
2024
Q3 		– Sell
-21,405
Closed -$123K – 328
2024
Q2 		$123K Buy
+21,405
New +$117K 0.12% 230

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oxford Asset Management's BVS Position: Q2 2025 in Review

Oxford Asset Management sold out of Bioventus (BVS) in Q2 2025, closing a stake of 15,838 shares — an estimated $145K sold.

Oxford Asset Management first reported a position in BVS in Q2 2024 and held it in 2 quarters. The position peaked at $145K in Q1 2025. 134 funds tracked by Wall St. Rank hold BVS as of Q2 2025.

  • Oxford Asset Management reported no remaining Bioventus position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 15,838 Bioventus shares in Q2 2025, an estimated $145K.
  • Oxford Asset Management first reported a position in Bioventus in Q2 2024 and held it in 2 quarters.
  • Oxford Asset Management's Bioventus position peaked at $145K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Bioventus as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.